These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19408074)

  • 21. Successful use of levosimendan in a patient during cardiopulmonary bypass.
    Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
    J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
    Axelsson B; Häggmark S; Svenmarker S; Johansson G; Gupta A; Tydén H; Wouters P; Haney M
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levosimendan, a new inotropic and vasodilator agent.
    Toller WG; Stranz C
    Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS; Sandell EP
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts.
    Kristof E; Szigeti G; Papp Z; Bodi A; Ball NA; Walsh RA; Edes I
    Basic Res Cardiol; 1999 Aug; 94(4):223-30. PubMed ID: 10505421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients.
    Severi L; Lappa A; Landoni G; Di Pirro L; Luzzi SJ; Caravetta P; Cipullo P; Menichetti A
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):632-6. PubMed ID: 21546269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
    Huang L; Weil MH; Tang W; Sun S; Wang J
    Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
    Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
    Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
    Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
    Lehtonen L
    Curr Heart Fail Rep; 2004 Sep; 1(3):136-44. PubMed ID: 16036037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
    Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
    Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
    Salgado Filho MF; Barral M; Barrucand L; Cavalcanti IL; Verçosa N
    PLoS One; 2015; 10(12):e0143315. PubMed ID: 26655803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New positive inotropic agents in the treatment of left ventricular dysfunction.
    De Luca L; Proietti P; Palombaro GL; Battagliese A; Celotto A; Bucciarelli Ducci C; Fedele F
    Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of Ca++-sensitizers for the treatment of heart failure.
    Lehmann A; Boldt J; Kirchner J
    Curr Opin Crit Care; 2003 Oct; 9(5):337-44. PubMed ID: 14508145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
    Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
    J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of acute cardiac failure by intracoronary administration of levosimendan.
    Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.